BioSpace News Archive

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, announced the pricing of its previously announced underwritten public offering of 51,250,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, at a public offering price of $0.30 per unit.

According to Emergen Research, the global rehabilitation robotics market size was USD 2.77 billion in 2020 and is expected to reach USD 11.38 billion in 2028 and register a revenue CAGR of 20.5% during the forecast period, 2021-2028.

Today, MedMira Inc. (MedMira) (TSXV: MIR) has received the CE mark for its REVEALCOVID-19® PLUS Total Antibody Test.